The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Artificial Lung Market Between 2026 And 2030?
The artificial lung market has seen swift growth over recent years. This market is expected to increase from $2.58 billion in 2025 to $2.88 billion in 2026, indicating a compound annual growth rate (CAGR) of 11.6%. The historical expansion of this market can be linked to several factors, including an increase in acute respiratory failure incidents, the early integration of heart lung machines into cardiothoracic surgery, a rise in the number of organ transplant procedures, the evolution of membrane artificial lung technology, and the growing application of extracorporeal life support systems.
The artificial lung market is anticipated to experience significant growth in the coming years. This market is projected to reach $4.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.4%. The expansion during the forecast period is attributed to an increasing demand for critical care life-support devices, a growing focus on portable and compact artificial lung systems, rising investment in advanced oxygenation membrane materials, a broader application in emergency and trauma care, and the increasing adoption of minimally invasive extracorporeal support solutions. Major trends expected in this period include a heightened demand for artificial lung systems in severe respiratory failure and critical care management, the rising use of extracorporeal support devices in complex cardiac and lung transplant surgeries, a developing preference for minimally invasive and temporary lung support alternatives to transplantation, the ongoing development of portable and transport-compatible artificial lung units for emergency care settings, and the expanding utilization of membrane-based artificial lung technologies for efficient gas exchange and long-term support.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp
Which Strong Drivers Are Impacting The Artificial Lung Market Growth?
The rising incidence of respiratory diseases is projected to spur the growth of the artificial lung market in the coming years. The increased prevalence of these conditions is attributed to a confluence of factors such as escalating air pollution, climate change, and shifts in lifestyle, imposing a substantial burden on public health. Artificial lungs play a crucial role in treating respiratory diseases by facilitating oxygenation and removing carbon dioxide from the bloodstream, thereby assisting or replacing compromised lung function. As an illustration, figures from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, estimated that approximately 8.5 million people in Australia, or 34% of the population, suffered from chronic respiratory conditions. This total included an estimated 2.8 million people, or 11% of the population, battling asthma, and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Therefore, the escalating prevalence of respiratory diseases is directly fueling the expansion of the artificial lung market.
What Segment Categories Shape The Artificial Lung Market Segment Landscape?
The artificial lung market covered in this report is segmented –
1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung
2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications
3) By End-Users: Hospital, Emergency Center, Other End-users
Subsegments:
1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines
2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines
3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung
4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung
Which Trends Are Contributing To Changes In The Artificial Lung Market?
Major companies in the artificial lung market are concentrating on developing innovative solutions, such as truly portable pneumatic ECMO systems, to broaden extracorporeal life support capabilities beyond the ICU and enable rapid transport and deployment in diverse settings. A pneumatic portable ECMO system operates using oxygen-supply-driven pneumatic pumps and integrated gas management to deliver extracorporeal oxygenation and circulatory support without needing external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a medical device company based in Germany, declared that MOBYBOX, known as the world’s first integrated portable pneumatic ECMO system, had successfully concluded its initial commercial applications in Europe; MOBYBOX weighs approximately 2.5 kg, functions entirely on oxygen supply thus requiring no battery or motor, incorporates Bionique Flow Technology for milder blood handling and better gas exchange, and has secured Medical Device Regulation certification for its early markets.
Who Are The Companies Operating Across The Artificial Lung Market Value Chain?
Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation
Get The Full Artificial Lung Market Report:
https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report
Which Region Leads The Artificial Lung Market In Overall Market Size?
North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Artificial Lung Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp
Browse Through More Reports Similar to the Global Artificial Lung Market 2026, By The Business Research Company
In Vitro Lung Model Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report
Artificial Intelligence Ai In Respiratory Diseases Market Report 2026
Respiratory Devices And Equipment Therapeutic Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model